CYRS-ONC3

N/A

Report date: 2025/06/11 11:23:35
NME

Base Information

Drug NameCYRS-ONC3
Drug Alias Nametargeted protein degrader (Cyrus Therapeutics)ONC-3CYRS-ONC3
ClassificationSmall molecules
Mechanisms of ActionGTPase Ras modulatorsAnticancer protein kinase inhibitorsMitogen-activated protein kinase modulators
TargetsMitogen-activated protein kinaseGTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyrus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyrus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A